Tapewire

Nasdaq · USD

TVTX

Travere Therapeutics, Inc.

Export transactions ↓
Tapewire entity
1562
SEC CIK
0001438533
Parsed reports
437

Last 12 months

Inside the activity.

0 purchase rows · 116 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202506
Jan 202605
Feb 2026017
Mar 202601
Apr 2026023
May 2026015
Jun 202602
Jul 202600
Aug 202605
Sep 2026041
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 17, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 8,282 $0.00 Strike: $22.40 $0.00
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 21

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,837

Underlying: Common Stock · 8,282 shares

Expires 2033-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_date: One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of January 31, 2023, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 17, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
SaleCommon Stock 8,282 $65.07 $538,917.19
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 14

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,066

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F9 · price: The weighted average sale price for the transaction reported was $65.0709, and the range of prices were between $65.00 and $65.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 17, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 8,282 $22.40 $185,516.80
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 13

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,348

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 17, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 108,493 $0.00 Strike: $23.34 $0.00
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · derivative · entry 14

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 108,493 shares

Expires 2029-01-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 17, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 6,802 $64.95 $441,795.34
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 11

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 432,886

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F8 · price: The weighted average sale price for the transaction reported was $64.9508, and the range of prices were between $64.84 and $65.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 17, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 101,691 $64.59 $6,567,875.94
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 10

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 439,688

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F7 · price: The weighted average sale price for the transaction reported was $64.5866, and the range of prices were between $63.84 and $64.83. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 17, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionCommon Stock 108,493 $23.34 $2,532,226.62
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 9

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 541,379

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
Exercise / conversionEmployee stock option (right to buy) · Derivative 57,500 $0.00 Strike: $26.88 $0.00
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · derivative · entry 16

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 57,500 shares

Expires 2031-01-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
Exercise / conversionEmployee stock option (right to buy) · Derivative 55,000 $0.00 Strike: $15.46 $0.00
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · derivative · entry 15

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 55,000 shares

Expires 2030-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
Exercise / conversionEmployee stock option (right to buy) · Derivative 350 $0.00 Strike: $17.96 $0.00
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · derivative · entry 14

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 350 shares

Expires 2029-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
SaleCommon Stock 47,746 $63.61 $3,037,247.20
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 11

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 98,197

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F7 · price: The weighted average sale price for the transaction reported was $63.6126, and the range of prices were between $63.47 and $63.96. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
SaleCommon Stock 65,104 $63.12 $4,109,397.03
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 10

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,943

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F6 · price: The weighted average sale price for the transaction reported was $63.1205, and the range of prices were between $62.47 and $63.4650. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
Exercise / conversionCommon Stock 57,500 $26.88 $1,545,600.00
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 9

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,047

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
Exercise / conversionCommon Stock 55,000 $15.46 $850,300.00
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 8

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 153,547

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
Exercise / conversionCommon Stock 350 $17.96 $6,286.00
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 7

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 98,547

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 17,717 $0.00 Strike: $26.88 $0.00
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 20

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 500

Underlying: Common Stock · 17,717 shares

Expires 2031-01-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 55,000 $0.00 Strike: $15.46 $0.00
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 19

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 55,000 shares

Expires 2030-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 100,000 $0.00 Strike: $11.25 $0.00
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 18

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2029-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
SaleCommon Stock 79,113 $63.65 $5,035,906.37
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 12

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,066

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F8 · price: The weighted average sale price for the transaction reported was $63.6546, and the range of prices were between $63.50 and $64.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
SaleCommon Stock 93,604 $63.25 $5,920,181.55
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 11

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 196,179

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F7 · price: The weighted average sale price for the transaction reported was $63.2471, and the range of prices were between $62.50 and $63.49. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 17,717 $26.88 $476,232.96
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 10

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 289,783

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 55,000 $15.46 $850,300.00
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 9

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 272,066

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 100,000 $11.25 $1,125,000.00
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 8

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 217,066

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 195,841 $0.00 Strike: $23.34 $0.00
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · derivative · entry 13

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,493

Underlying: Common Stock · 195,841 shares

Expires 2029-01-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 96,125 $63.64 $6,117,289.26
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 8

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 432,886

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F6 · price: The weighted average sale price for the transaction reported was $63.6389, and the range of prices were between $63.51 and $64.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 99,716 $63.26 $6,307,964.36
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 7

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 529,011

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F5 · price: The weighted average sale price for the transaction reported was $63.2593, and the range of prices were between $62.51 and $63.505. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 16, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionCommon Stock 195,841 $23.34 $4,570,928.94
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 6

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 628,727

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
Exercise / conversionEmployee stock option (right to buy) · Derivative 39,650 $0.00 Strike: $17.96 $0.00
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · derivative · entry 13

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 350

Underlying: Common Stock · 39,650 shares

Expires 2029-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
Exercise / conversionEmployee stock option (right to buy) · Derivative 39,000 $0.00 Strike: $25.25 $0.00
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · derivative · entry 12

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 39,000 shares

Expires 2028-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
SaleCommon Stock 270 $65.31 $17,633.70
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 6

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 98,197

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
SaleCommon Stock 3,000 $63.65 $190,952.40
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 5

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 98,467

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F5 · price: The weighted average sale price for the transaction reported was $63.6508, and the range of prices were between $63.49 and $63.99. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
SaleCommon Stock 29,021 $62.66 $1,818,316.56
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 4

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 101,467

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F4 · price: The weighted average sale price for the transaction reported was $62.6552 and the range of prices were between $62.41 and $63.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
SaleCommon Stock 63,907 $61.99 $3,961,850.56
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 3

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,488

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F3 · price: The weighted average sale price for the transaction reported was $61.994, and the range of prices were between $61.405 and $62.40. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
Exercise / conversionCommon Stock 39,650 $17.96 $712,114.00
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 2

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 194,395

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
ROTE WILLIAM E.Chief Research Officer
Exercise / conversionCommon Stock 39,000 $25.25 $984,750.00
Disclosure

SEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 1

ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,745

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 271 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 29, 2026.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 36,526 $0.00 Strike: $8.93 $0.00
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 17

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,474

Underlying: Common Stock · 36,526 shares

Expires 2034-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of January 31, 2024, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 1,381 $0.00 Strike: $22.40 $0.00
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 16

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,119

Underlying: Common Stock · 1,381 shares

Expires 2033-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_date: One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of January 31, 2023, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 39,283 $0.00 Strike: $26.88 $0.00
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 15

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,217

Underlying: Common Stock · 39,283 shares

Expires 2031-01-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
SaleCommon Stock 1,431 $65.31 $93,457.61
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 7

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,066

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F6 · price: The weighted average sale price for the transaction reported was $65.3093, and the range of prices were between $65.30 and $65.31. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
SaleCommon Stock 1,400 $63.65 $89,112.94
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 6

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,497

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F5 · price: The weighted average sale price for the transaction reported was $63.6521, and the range of prices were between $63.56 and $63.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
SaleCommon Stock 27,421 $62.59 $1,716,379.11
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 5

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,897

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F4 · price: The weighted average sale price for the transaction reported was $62.5936, and the range of prices were between $62.43 and $63.27. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
SaleCommon Stock 71,938 $62.05 $4,463,875.19
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 4

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 147,318

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F3 · price: The weighted average sale price for the transaction reported was $62.0517, and the range of prices were between $61.43 and $62.42. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 36,526 $8.93 $326,177.18
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 3

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 219,256

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 1,381 $22.40 $30,934.40
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 2

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 182,730

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:35 UTC
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 39,283 $26.88 $1,055,927.04
Disclosure

SEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 1

Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 181,349

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,382 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 29, 2026.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:33 UTC
Inrig JulaEVP, Head of R&D & CMO
Exercise / conversionEmployee stock option (right to buy) · Derivative 32,395 $0.00 Strike: $8.93 $0.00
Disclosure

SEC source: 0001902368-26-000008 · form4-09182026_010947.xml · derivative · entry 6

Inrig Jula · CIK 0001902368 · EVP, Head of R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,605

Underlying: Common Stock · 32,395 shares

Expires 2034-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of January 31, 2024, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:33 UTC
Inrig JulaEVP, Head of R&D & CMO
SaleCommon Stock 400 $65.31 $26,124.00
Disclosure

SEC source: 0001902368-26-000008 · form4-09182026_010947.xml · nonDerivative · entry 5

Inrig Jula · CIK 0001902368 · EVP, Head of R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100,491

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:33 UTC
Inrig JulaEVP, Head of R&D & CMO
SaleCommon Stock 1,600 $63.69 $101,896.00
Disclosure

SEC source: 0001902368-26-000008 · form4-09182026_010947.xml · nonDerivative · entry 4

Inrig Jula · CIK 0001902368 · EVP, Head of R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100,891

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F4 · price: The weighted average sale price for the transaction reported was $63.685, and the range of prices were between $63.58 and $63.86. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:33 UTC
Inrig JulaEVP, Head of R&D & CMO
SaleCommon Stock 17,284 $62.62 $1,082,396.67
Disclosure

SEC source: 0001902368-26-000008 · form4-09182026_010947.xml · nonDerivative · entry 3

Inrig Jula · CIK 0001902368 · EVP, Head of R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,491

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F3 · price: The weighted average sale price for the transaction reported was $62.6242, and the range of prices were between $62.40 and $63.365. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:33 UTC
Inrig JulaEVP, Head of R&D & CMO
SaleCommon Stock 25,390 $62.02 $1,574,604.01
Disclosure

SEC source: 0001902368-26-000008 · form4-09182026_010947.xml · nonDerivative · entry 2

Inrig Jula · CIK 0001902368 · EVP, Head of R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,775

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F2 · price: The weighted average sale price for the transaction reported was $62.0167, and the range of prices were between $61.40 and $62.39. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.